HUM
31
-3
MA
71
7
NWS
94
2
FOXA
55
2
SLB
35
3
UPS
22
2
NOC
47
2
C
67
2
GOOG
67
4
TJX
50
2
STZ
45
2
TAP
56
3
MU
55
-4
CAG
39
2
XYL
43
4
FFIV
64
-2
EXC
72
3
VTR
58
3
ITW
50
2
NWL
35
3
HUM
31
-3
MA
71
7
NWS
94
2
FOXA
55
2
SLB
35
3
UPS
22
2
NOC
47
2
C
67
2
GOOG
67
4
TJX
50
2
STZ
45
2
TAP
56
3
MU
55
-4
CAG
39
2
XYL
43
4
FFIV
64
-2
EXC
72
3
VTR
58
3
ITW
50
2
NWL
35
3
Financhill
Back

Infosys Vs. Bright Minds Biosciences Industry Stock Comparison

Sell
41

INFY
Infosys

Last Price:
$17.46
Seasonality Move:
8.33%
Sell
45

DRUG
Bright Minds Biosciences

Last Price:
$30.20
Seasonality Move:
-4.26%
Sell
41
Infosys (INFY) is a Sell

Is Infosys a Buy, Sell or Hold?

  • The current Infosys [INFY] share price is $17.57. The Score for INFY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • INFY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $30.89. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

INFY Stock Price Chart

What is Infosys's stock price today?

  • The Infosys share price today is $17.57
    The current trend is relatively stagnant and INFY is experiencing slight buying pressure.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $30.89
    The current trend is moderately bearish and DRUG is experiencing selling pressure, which indicates risk of future bearish movement.

INFY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 49.72 Sell
Chaikin Money Flow: 3680335 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.64 - 18.16) Buy
Bollinger Bands (100): (18.25 - 22.71) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.27 Buy
Relative Strength Index (14 RSI): 42.54 Sell
Chaikin Money Flow: -16659 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.29 - 35.33) Sell
Bollinger Bands (100): (32.31 - 40.39) Sell

INFY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.06 Buy
20-day SMA: 17.12 Buy
50-day SMA: 18.59 Sell
200-day SMA: 21.3 Sell
8-day EMA: 17.23 Buy
20-day EMA: 17.36 Buy
50-day EMA: 18.45 Sell
200-day EMA: 20.15 Sell

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.73 Sell
20-day SMA: 32 Sell
50-day SMA: 34.24 Sell
200-day SMA: 25.61 Buy
8-day EMA: 32.23 Sell
20-day EMA: 30.44 Buy
50-day EMA: 22.04 Buy
200-day EMA: 8.05 Buy

Infosys Earnings Growth & INFY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.01 per share, an increase this year of $0.04 per share, and an increase next year of $0.04 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.58 per share, and a decrease next year of $1.66 per share.

Infosys Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):